Lixte Biotechnology Holdings Stock Technical Analysis

LIXTW Stock  USD 0.02  0.01  25.00%   
As of the 30th of January, Lixte Biotechnology secures the Downside Deviation of 21.65, risk adjusted performance of 0.0555, and Mean Deviation of 10.11. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lixte Biotechnology, as well as the relationship between them. Please verify Lixte Biotechnology standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Lixte Biotechnology Holdings is priced some-what accurately, providing market reflects its recent price of 0.021 per share. As Lixte Biotechnology appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.

Lixte Biotechnology Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Lixte, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Lixte
  
Lixte Biotechnology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Lixte Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Lixte Biotechnology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Lixte Biotechnology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Lixte Biotechnology Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Lixte Biotechnology volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Lixte Biotechnology Trend Analysis

Use this graph to draw trend lines for Lixte Biotechnology Holdings. You can use it to identify possible trend reversals for Lixte Biotechnology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Lixte Biotechnology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Lixte Biotechnology Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Lixte Biotechnology Holdings applied against its price change over selected period. The best fit line has a slop of   0.0001  , which may suggest that Lixte Biotechnology Holdings market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Lixte Biotechnology price change compared to its average price change.

About Lixte Biotechnology Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Lixte Biotechnology Holdings on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Lixte Biotechnology Holdings based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Lixte Biotechnology price pattern first instead of the macroeconomic environment surrounding Lixte Biotechnology. By analyzing Lixte Biotechnology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Lixte Biotechnology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Lixte Biotechnology specific price patterns or momentum indicators. Please read more on our technical analysis page.

Lixte Biotechnology January 30, 2025 Technical Indicators

Most technical analysis of Lixte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lixte from various momentum indicators to cycle indicators. When you analyze Lixte charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for Lixte Stock Analysis

When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.